Dx Deal Roundup: Top 10 Clinical Lab M&A Deals of 2023
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.
Seven months into the year, there were already four reported deals valued at over $1 billion in 2023, as many as in all of 2022.
Proposed rule would require businesses to undergo even more stringent review to secure regulatory approval for such deals.
Diagnostics companies that invested heavily in COVID-19 products are relying on M&A transactions to restructure and transition.